Dr. Wes: “If re-used instruments are being used in a laboratory, I believe that patients should be made aware and have this included in their informed consent, with any potential risks spelled out. Further, if a patient knew they could apply some of the cost savings of re-processing toward their procedure costs, then perhaps they’d be more willing to agree to the practice.”
Related Stories
More in Uncategorized
Comments
Previous post: Spiriva and the FDA
Next post: Urinary retention in a 14-year old




